ARCHIVES

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

This article is from The Cancer Letter archive.

Vol. 13 No. 09 | February 27, 1987

Download PDF Visit The Full Archive

Related Articles

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

In Brief: Schmidt Sells OMB On Training Grants, But Weinberger Is The One To Convince

December 21, 1973

Alan Rabson Named Acting NCI Director

October 5, 2001

Cancer Training Programs Fairing Fairley Well

December 1, 1989

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

Stronger Measures Needed To Reduce U.S. Smoking, IOM Says.

June 1, 2007